Patient-reported outcomes and considerations in the management of COPD: focus on aclidinium.
about
Serum Metabolite Biomarkers Discriminate Healthy Smokers from COPD SmokersBronchodilator efficacy of 18 μg once-daily tiotropium inhalation via Discair® versus HandiHaler® in adults with chronic obstructive pulmonary disease: randomized, active-controlled, parallel-group, open-label, Phase IV trialTreatment options for moderate-to-very severe chronic obstructive pulmonary disease.
P2860
Patient-reported outcomes and considerations in the management of COPD: focus on aclidinium.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Patient-reported outcomes and ...... of COPD: focus on aclidinium.
@en
type
label
Patient-reported outcomes and ...... of COPD: focus on aclidinium.
@en
prefLabel
Patient-reported outcomes and ...... of COPD: focus on aclidinium.
@en
P2093
P2860
P50
P356
P1476
Patient-reported outcomes and ...... of COPD: focus on aclidinium.
@en
P2093
Carmen Calero
Cecilia Lopez-Ramirez
Jose Luis Lopez-Campos
P2860
P304
P356
10.2147/PPA.S55009
P407
P577
2015-01-17T00:00:00Z